Pfizer on buying spree with AstraZeneca antibiotics deal 24.08.2016 21:22 Chicago Sun-Times Pfizer says it will pay $1.5 billion for rights to AstraZeneca's portfolio of approved and experimental antibiotic and antifungal pills.